Clustering data with hclust algorithm for (Study ST000664)

(Analysis AN001014)
MetaboliteStructureF1F2F3F4F5F6F7F8
plasmenyl-PE 36:5; [M-H]-@6.37ME179349NANANA0.722.43NA0.671.11
PC 39:6; [M-Ac-H]-@6.61ME179254NANANA0.851.56NA0.591.38
plasmenyl-PE 36:4; [M-H]-@6.72ME179348NANANA0.801.50NA0.761.35
CL 68:1; [M-2H](2-)@7.36ME179169NANANA1.042.10NA0.620.76
CL 72:1; [M-2H](2-)@7.76ME179172NANANA0.831.88NA0.781.08
PE 35:1; [M-H]-@7.17ME179279NANANA0.871.83NA0.830.98
PC 37:5; [M-Ac-H]-@6.15ME179242NANANA1.031.71NA0.750.85
plasmenyl-PE 34:1; [M-H]-@7.24ME179342NANANA0.951.79NA0.800.89
CL 76:8; [M-2H](2-)@6.86ME179184NANANA0.680.51NA1.221.58
PA 40:4; [M-H]-@6.87ME179198NANANA0.640.95NA1.031.62
PC 44:12; [M-Ac-H]-@5.69ME179269NANANA0.791.04NA0.771.57
PI 36:2; [M-H]-@5.95ME179319NANANA1.290.77NA1.040.56
PE 36:6; [M-H]-@5.66ME179290NANANA1.390.59NA0.840.68
PE 38:1; [M-H]-@7.41ME179293NANANA1.250.52NA1.020.78
PC 32:3; [M-Ac-H]-@5.26ME179213NANANA1.050.96NA1.560.36
PI 38:6; [M-H]-@5.19ME179325NANANA1.201.14NA1.190.39
PI 34:2; [M-H]-@5.33ME179317NANANA1.170.99NA1.240.46
PC 26:0; [M-Ac-H]-@4.59ME179201NANANA1.200.89NA1.300.41
PG 34:2; [M-H]-@5.52ME179310NANANA1.240.82NA1.240.43
PC 39:3; [M-Ac-H]-@7.46ME179251NANANA0.761.81NA1.250.76
plasmenyl-PE 36:2; [M-H]-@7.38ME179346NANANA0.791.42NA1.360.80
plasmenyl-PE 38:2; [M-H]-@7.95ME179351NANANA0.841.21NA1.350.81
PC 31:1; [M-Ac-H]-@5.86ME179208NANANA1.321.12NA0.820.56
PG 35:3; [M-H]-@6.36ME179311NANANA1.291.11NA0.700.75
PE 35:0; [M-H]-@7.65ME179278NANANA1.271.43NA0.690.63
PC 38:4; [M-Ac-H]-@6.83ME179247NANANA1.161.24NA0.740.85
PC 38:6; [M-Ac-H]-@6.12ME179249NANANA1.201.32NA0.640.86
PC 36:5; [M-Ac-H]-@5.76ME179236NANANA1.121.46NA0.760.80
PC 38:5; [M-Ac-H]-@6.47ME179248NANANA1.051.46NA0.820.86
PE 40:6; [M-H]-@6.97ME179305NANANA1.181.34NA0.750.76
PI 36:4; [M-H]-@5.31ME179321NANANA1.121.36NA0.860.75
PC 36:6; [M-Ac-H]-@5.52ME179237NANANA1.121.30NA0.840.80
PC 40:4; [M-Ac-H]-@7.41ME179258NANANA1.091.30NA0.820.87
PC 35:0; [M-Ac-H]-@7.12ME179224NANANA1.041.34NA0.681.08
PC 40:5; [M-Ac-H]-@7.13ME179259NANANA1.191.45NA0.600.84
PC 40:6; [M-Ac-H]-@6.78ME179260NANANA1.151.39NA0.570.96
PI 40:6; [M-H]-@5.87ME179327NANANA1.131.43NA0.600.96
PE 39:6; [M-H]-@6.61ME179302NANANA1.051.12NA0.990.86
PC 34:1; [M-Ac-H]-@6.75ME179218NANANA1.061.04NA0.930.95
PE 40:5; [M-H]-@7.17ME179304NANANA1.071.08NA0.930.90
CL 82:9; [M-2H](2-)@6.39ME179192NANANA1.081.16NA1.000.78
PE 35:4; [M-H]-@6.14ME179281NANANA1.091.19NA1.010.74
PC 36:1; [M-Ac-H]-@7.38ME179231NANANA1.121.23NA0.900.79
PC 42:5; [M-Ac-H]-@7.55ME179268NANANA1.081.21NA0.890.87
lysoPE 16:1; [M-H]-@1.33ME179332NANANA1.071.18NA0.940.85
lysoPE 20:3; [M-H]-@1.70ME179336NANANA1.091.16NA0.910.85
PC 32:1; [M-Ac-H]-@6.18ME179211NANANA1.131.11NA1.050.66
PI 34:1; [M-H]-@5.75ME179316NANANA1.161.17NA0.990.64
PG 36:2; [M-H]-@6.15ME179314NANANA1.121.02NA0.990.79
PC 36:4; [M-Ac-H]-@6.16ME179235NANANA1.141.03NA0.940.80
PE 40:7; [M-H]-@6.48ME179306NANANA1.161.03NA0.930.77
PC 30:1; [M-Ac-H]-@5.52ME179205NANANA1.151.10NA0.970.70
PC 37:1; [M-Ac-H]-@7.67ME179238NANANA1.131.12NA0.940.77
PE 36:5; [M-H]-@6.10ME179289NANANA1.151.09NA0.920.78
PE 38:6; [M-H]-@6.23ME179299NANANA1.251.03NA0.910.63
CL 78:11; [M-2H](2-)@6.17ME179185NANANA1.200.98NA0.930.72
PI 40:5; [M-H]-@6.20ME179326NANANA1.220.99NA0.910.71
PE 36:1; [M-H]-@6.78ME179283NANANA0.960.99NA1.061.02
PC 44:3; [M-Ac-H]-@8.67ME179270NANANA0.910.99NA1.121.04
PE 36:4; [M-H]-@6.30ME179288NANANA0.940.97NA1.111.01
lysoPE 16:0; [M-H]-@1.76ME179331NANANA0.991.03NA1.001.01
PC 30:0; [M-Ac-H]-@6.06ME179204NANANA0.990.89NA1.071.00
PE 37:3; [M-H]-@6.97ME179291NANANA1.040.90NA1.010.98
CL 86:15; [M-2H](2-)@6.55ME179193NANANA1.030.96NA1.010.97
PI 38:5; [M-H]-@5.44ME179324NANANA1.010.94NA1.001.01
PC 33:1; [M-Ac-H]-@6.64ME179215NANANA1.000.98NA1.140.86
PC 36:2; [M-Ac-H]-@6.94ME179232NANANA1.040.95NA1.140.81
PI 36:3; [M-H]-@5.45ME179320NANANA1.071.02NA1.130.73
plasmenyl-PE 38:1; [M-H]-@8.31ME179350NANANA1.080.98NA1.060.80
PE 38:5; [M-H]-@6.59ME179298NANANA0.940.98NA1.220.90
PC 32:0; [M-Ac-H]-@6.69ME179210NANANA1.001.02NA1.040.96
PC 36:3; [M-Ac-H]-@6.49ME179233NANANA0.991.02NA1.070.93
PE 38:3; [M-H]-@7.30ME179296NANANA0.991.05NA1.080.91
lysoPE 18:1; [M-H]-@1.93ME179334NANANA0.951.04NA1.150.92
PA 41:4; [M-H]-@6.57ME179199NANANA0.961.04NA1.140.90
PC 33:3; [M-Ac-H]-@5.84ME179217NANANA1.001.06NA1.110.86
PC 38:2; [M-Ac-H]-@7.55ME179245NANANA1.021.05NA1.090.86
PC 34:4; [M-Ac-H]-@5.63ME179222NANANA1.031.14NA1.140.73
PE 33:2; [M-H]-@6.16ME179274NANANA0.911.19NA1.130.93
PC 42:3; [M-Ac-H]-@8.17ME179266NANANA1.260.77NA0.710.94
PC 40:9; [M-Ac-H]-@5.54ME179263NANANA1.270.94NA0.810.75
PC 40:3; [M-Ac-H]-@7.67ME179257NANANA1.330.81NA0.710.81
PI 38:4; [M-H]-@5.95ME179323NANANA1.300.88NA0.750.79
PI 38:3; [M-H]-@6.15ME179322NANANA1.110.91NA1.000.86
CL 74:1; [M-2H](2-)@6.80ME179175NANANA1.110.97NA0.890.94
PC 35:4; [M-Ac-H]-@6.05ME179228NANANA1.170.85NA0.840.93
PC 42:4; [M-Ac-H]-@7.99ME179267NANANA1.140.68NA1.000.91
PE 38:2; [M-H]-@7.59ME179294NANANA1.200.82NA1.010.73
PI 36:1; [M-H]-@6.38ME179318NANANA1.190.76NA1.030.76
CL 76:6; [M-2H](2-)@6.67ME179182NANANA1.090.94NA0.771.11
PC 37:4; [M-Ac-H]-@6.72ME179241NANANA1.070.98NA0.841.04
PC 31:0; [M-Ac-H]-@6.32ME179207NANANA1.161.07NA0.700.98
plasmenyl-PE 42:4; [M-H]-@8.27ME179361NANANA1.151.01NA0.780.96
lysoPE 22:6; [M-H]-@1.36ME179341NANANA1.051.12NA0.761.09
PC 40:7; [M-Ac-H]-@6.31ME179261NANANA1.091.17NA0.780.97
CL 76:7; [M-2H](2-)@6.79ME179183NANANA0.931.14NA0.911.14
plasmenyl-PE 40:3; [M-H]-@8.13ME179356NANANA0.941.12NA0.861.18
lysoPE 18:0; [M-H]-@2.56ME179333NANANA0.991.15NA0.841.11
PC 37:6; [M-Ac-H]-@5.93ME179243NANANA1.031.10NA0.861.05
PE 37:4; [M-H]-@6.72ME179292NANANA0.991.08NA0.871.11
CL 78:5; [M-2H](2-)@7.31ME179189NANANA0.971.04NA0.941.09
PE 38:4; [M-H]-@6.99ME179297NANANA1.000.97NA0.901.12
PC 38:1; [M-Ac-H]-@7.90ME179244NANANA0.960.97NA0.951.13
lysoPE 20:4; [M-H]-@1.42ME179337NANANA0.980.95NA0.981.08
lysoPE 22:5; [M-H]-@1.64ME179340NANANA1.000.95NA0.941.09
PE 40:4; [M-H]-@7.49ME179303NANANA0.890.97NA0.971.23
CL 78:7; [M-2H](2-)@6.71ME179190NANANA0.940.88NA0.921.23
PC 35:3; [M-Ac-H]-@6.24ME179227NANANA0.940.92NA0.971.18
PE 39:5; [M-H]-@6.86ME179301NANANA0.931.13NA0.721.34
PC 42:10; [M-Ac-H]-@5.81ME179264NANANA0.961.21NA0.751.22
PG 33:0; [M-H]-@6.13ME179308NANANA1.031.19NA0.641.21
plasmenyl-PE 38:4; [M-H]-@7.30ME179353NANANA0.831.09NA0.961.29
CL 82:15; [M-2H](2-)@6.04ME179191NANANA0.851.20NA0.881.28
PE 40:8; [M-H]-@6.06ME179307NANANA0.901.12NA0.831.28
plasmenyl-PE 42:5; [M-H]-@7.94ME179362NANANA0.911.09NA0.831.29
plasmenyl-PE 40:4; [M-H]-@7.82ME179357NANANA0.780.96NA1.001.40
lysoPE 20:5; [M-H]-@1.13ME179338NANANA0.801.07NA0.871.45
plasmenyl-PE 42:6; [M-H]-@7.82ME179363NANANA0.811.06NA0.901.39
PS 38:4; [M-H]-@6.06ME179329NANANA0.920.88NA0.751.44
PG 38:4; [M-H]-@6.13ME179315NANANA0.970.98NA0.771.30
PS 36:1; [M-H]-@6.46ME179328NANANA1.020.92NA0.791.21
PC 19:2; [M-Ac-H]-@1.43ME179200NANANA0.781.57NA1.150.94
plasmenyl-PE 34:2; [M-H]-@6.79ME179343NANANA0.701.53NA1.121.14
plasmenyl-PE 36:1; [M-H]-@7.80ME179345NANANA0.761.58NA1.051.07
CerP 21:0; [M-H]-@2.12ME179194NANANA0.891.34NA0.791.23
PC 34:2; [M-Ac-H]-@4.49ME179219NANANA0.931.23NA0.891.11
plasmenyl-PE 38:5; [M-H]-@6.84ME179354NANANA0.871.33NA0.901.16
plasmenyl-PE 40:6; [M-H]-@7.21ME179360NANANA0.881.28NA0.941.14
plasmenyl-PE 38:3; [M-H]-@7.60ME179352NANANA0.881.19NA0.981.14
plasmenyl-PE 40:5; [M-H]-@7.39ME179358NANANA0.861.13NA1.011.16
plasmenyl-PE 40:5; [M-H]-@7.62ME179359NANANA0.871.13NA1.011.16
PA 38:3; [M-H]-@7.02ME179197NANANA0.771.21NA1.051.23
PC 40:1; [M-Ac-H]-@8.45ME179255NANANA0.811.17NA1.101.15
PG 36:0; [M-H]-@6.94ME179312NANANA0.791.18NA1.091.18
PS 38:5; [M-H]-@5.53ME179330NANANA0.821.34NA1.051.09
plasmenyl-PE 34:3; [M-H]-@6.46ME179344NANANA0.801.24NA1.151.08
plasmenyl-PE 36:3; [M-H]-@6.97ME179347NANANA0.801.24NA1.161.07
PC 35:5; [M-Ac-H]-@5.60ME179229NANANA0.931.60NA0.741.08
PA 34:0; [M-H]-@7.68ME179195NANANA0.921.44NA0.841.09
PC 39:5; [M-Ac-H]-@6.71ME179253NANANA0.941.49NA0.761.09
PG 36:1; [M-H]-@6.50ME179313NANANA0.911.44NA1.000.94
PC 33:0; [M-Ac-H]-@7.07ME179214NANANA0.931.40NA0.990.93
plasmenyl-PE 38:6; [M-H]-@6.64ME179355NANANA0.931.36NA0.990.95
PC 39:4; [M-Ac-H]-@7.31ME179252NANANA0.981.28NA0.930.96
PC 37:3; [M-Ac-H]-@6.95ME179240NANANA0.901.37NA0.941.05
PC 36:0; [M-Ac-H]-@7.88ME179230NANANA0.941.34NA0.960.98
PE 36:0; [M-H]-@7.93ME179282NANANA0.941.34NA0.921.01
PC 38:7; [M-Ac-H]-@5.63ME179250NANANA1.031.45NA0.940.79
PC 38:3; [M-Ac-H]-@7.18ME179246NANANA1.011.30NA0.980.85
PE 36:1; [M-H]-@7.50ME179284NANANA1.001.32NA0.990.85
PC 32:2; [M-Ac-H]-@5.70ME179212NANANA0.980.83NA1.390.74
CL 66:1; [M-2H](2-)@6.32ME179168NANANA0.950.87NA1.470.69
PC 37:2; [M-Ac-H]-@7.32ME179239NANANA1.010.89NA1.420.62
PA 36:1; [M-H]-@6.81ME179196NANANA1.080.68NA1.320.70
PC 34:3; [M-Ac-H]-@5.88ME179221NANANA0.980.89NA1.250.83
PE 34:3; [M-H]-@6.11ME179277NANANA1.020.81NA1.300.76
PE 36:2; [M-H]-@7.05ME179286NANANA1.050.85NA1.260.74
lysoPE 22:4; [M-H]-@1.96ME179339NANANA1.090.81NA1.180.76
PE 34:2; [M-H]-@6.47ME179276NANANA1.090.78NA1.160.80
PC 34:2; [M-Ac-H]-@6.31ME179220NANANA1.010.80NA1.170.92
PE 38:2; [M-H]-@6.99ME179295NANANA1.050.85NA1.120.88
CL 74:3; [M-2H](2-)@5.64ME179176NANANA0.960.50NA1.271.05
CL 76:10; [M-2H](2-)@6.67ME179179NANANA0.990.69NA1.230.94
CL 78:3; [M-2H](2-)@7.08ME179186NANANA1.020.58NA1.300.88
PC 42:2; [M-Ac-H]-@8.73ME179265NANANA1.030.61NA1.260.88
PC 40:2; [M-Ac-H]-@8.20ME179256NANANA0.770.63NA1.541.04
PC 28:0; [M-Ac-H]-@5.36ME179202NANANA0.830.93NA1.430.90
PE 32:0; [M-H]-@6.81ME179271NANANA0.820.86NA1.400.99
CL 78:3; [M-2H](2-)@7.57ME179187NANANA0.920.65NA1.380.93
PE 36:2; [M-H]-@6.35ME179285NANANA0.970.65NA1.370.87
CL 74:3; [M-2H](2-)@6.36ME179177NANANA0.890.76NA1.400.90
CL 74:5; [M-2H](2-)@6.46ME179178NANANA0.910.67NA1.450.88
PE 36:3; [M-H]-@6.60ME179287NANANA0.910.72NA1.460.84
CL 70:5; [M-2H](2-)@6.06ME179171NANANA0.940.66NA1.530.75
PE 32:1; [M-H]-@6.32ME179272NANANA0.860.76NA1.550.81
PC 36:4; [M-Ac-H]-@7.52ME179234NANANA0.870.69NA1.101.29
CL 76:3; [M-2H](2-)@7.14ME179181NANANA0.780.77NA1.281.21
PE 39:4; [M-H]-@7.73ME179300NANANA0.800.62NA1.251.29
CL 78:4; [M-2H](2-)@7.08ME179188NANANA0.831.03NA1.161.13
PG 33:1; [M-H]-@6.58ME179309NANANA0.870.93NA1.171.09
PC 31:1; [M-Ac-H]-@6.55ME179209NANANA1.000.82NA0.971.11
CL 72:7; [M-2H](2-)@6.14ME179174NANANA0.980.86NA1.031.08
PC 35:1; [M-Ac-H]-@7.17ME179225NANANA1.010.85NA1.021.05
PC 34:5; [M-Ac-H]-@5.24ME179223NANANA0.960.77NA1.021.16
PE 35:2; [M-H]-@6.79ME179280NANANA1.010.73NA1.041.06
CL 76:12; [M-2H](2-)@6.67ME179180NANANA1.030.75NA0.971.11
PC 40:8; [M-Ac-H]-@5.88ME179262NANANA1.020.70NA1.001.12
CL 70:1; [M-2H](2-)@6.53ME179170NANANA0.890.73NA1.271.06
CL 72:3; [M-2H](2-)@6.83ME179173NANANA0.920.70NA1.201.09
PC 33:2; [M-Ac-H]-@6.07ME179216NANANA0.950.79NA1.270.92
PE 34:1; [M-H]-@6.92ME179275NANANA0.940.83NA1.240.95
PC 28:1; [M-Ac-H]-@4.81ME179203NANANA1.000.80NA1.091.01
lysoPE 18:2; [M-H]-@1.45ME179335NANANA0.960.86NA1.141.00
PC 35:2; [M-Ac-H]-@6.69ME179226NANANA0.920.83NA1.171.05
PC 30:2; [M-Ac-H]-@5.00ME179206NANANA0.940.47NA1.690.68
PE 33:1; [M-H]-@6.63ME179273NANANA0.830.94NA1.670.65

Factors:

F1diagnosis:BP | gender:F
F2diagnosis:BP | gender:M
F3diagnosis:BP! | gender:M
F4diagnosis:BPI | gender:F
F5diagnosis:BPI | gender:M
F6diagnosis:BPL | gender:M
F7diagnosis:HC | gender:F
F8diagnosis:HC | gender:M
Data matrix
  logo